Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
Allergy Therapeutics PLC (GB:AGY)
LSE:AGY
Allergy Therapeutics (AGY) Stock Price & Analysis
0 Followers
AGY Stock Chart & Stats
Day’s Range0p - 0p
52-Week Range4.00p - 27.00p
Previous Close6.25p
Volume0.00
Average Volume (3M)1.55M
Market Cap
52.26M
Enterprise Value3.25B
Total Cash (Recent Filing)£20.52M
Total Debt (Recent Filing)£10.53M
Price to Earnings (P/E)-3.2
Beta0.46
Next Earnings
Sep 27, 2023EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding679,104,621
10 Day Avg. Volume183,019
30 Day Avg. Volume1,546,466
Standard Deviation0.16
R-Squared0.09
Alpha0.00375
Financial Highlights & Ratios
Price to Book (P/B)1.27
Price to Sales (P/S)5.50
Price to Cash Flow (P/CF)17.50
P/FCF Ratio-2.10
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
AGY FAQ
What was Allergy Therapeutics PLC’s price range in the past 12 months?
Allergy Therapeutics PLC lowest stock price was 4.00p and its highest was 27.00p in the past 12 months.
What is Allergy Therapeutics PLC’s market cap?
Currently, no data Available
When is Allergy Therapeutics PLC’s upcoming earnings report date?
Allergy Therapeutics PLC’s upcoming earnings report date is Sep 27, 2023 which is in 183 days.
How were Allergy Therapeutics PLC’s earnings last quarter?
Currently, no data Available
Is Allergy Therapeutics PLC overvalued?
According to Wall Street analysts Allergy Therapeutics PLC’s price is currently Overvalued.
Does Allergy Therapeutics PLC pay dividends?
Allergy Therapeutics PLC does not currently pay dividends.
What is Allergy Therapeutics PLC’s EPS estimate?
Allergy Therapeutics PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Allergy Therapeutics PLC have?
Allergy Therapeutics PLC has 679,104,600 shares outstanding.
What happened to Allergy Therapeutics PLC’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Allergy Therapeutics PLC?
Currently, no hedge funds are holding shares in GB:AGY
---
Allergy Therapeutics Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-75.96%
12-Months-Change
Fundamentals
Return on Equity
-31.69%
Trailing 12-Months
Asset Growth
-16.47%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Allergy Therapeutics PLC
Allergy Therapeutics PLC is active in the healthcare sector in the United Kingdom. It is a pharmaceutical company mainly engaged in the treatment and prevention of allergy with aluminium-free products. The company's geographical segment includes Central Europe; Southern Europe and the Rest of the World. It generates maximum revenue from Central Europe which includes Germany and other countries.
---
Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.
---